InvestorsHub Logo
Followers 20
Posts 5331
Boards Moderated 0
Alias Born 01/04/2012

Re: silvr_surfr post# 12658

Sunday, 05/09/2021 6:12:25 PM

Sunday, May 09, 2021 6:12:25 PM

Post# of 14871
Silvr, it look like in November 2020 Perrigo (who acquired Kionex from Paddock Labs) temporarily discontinued the drug and could not estimate when the product would be manufactured again. It looks like an API shortage was creating a shortage, as CMP was using available powder to manufacture the suspension.

See page 49 and 50

Published May 5, 2021 -Perrigo divested Kionex suspension and sodium polystyrene sulfonate (sorbitol-free) suspension to ANI pharmaceuticals. ANI Pharmaceuticals is not currently marketing sodium polystyrene sulfonate suspension.

Kionex sale

It is probably one of the drugs repatriating manufacturing to North America. The CEO mentioned this as a strategy for growth. I expect more such deals will follow.

More news to be announced post merger.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News